The Galien Forum USA 2019

PANEL
5

Chair
Bengt Samuelsson
Nobel Laureate
Former President,
Karolinska Institute
Former Chairman, 
Nobel Foundation

Panelists
Steve Rosenberg
Senior Vice President & General Manager
Oracle Health Sciences

Magnus Settergren
Assoc Prof and Interventional Cardiologist
Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Eric Topol
Executive Vice President and Chair
Innovative Medicine Scripps Research
Director & Founder
Scripps Research Translational Institute
Author, Deep Learning

Panel Intro

The marriage of technology and medicine: Bringing out the best in each other


Chair
Bengt Samuelsson
Nobel Laureate
Former President,
Karolinska Institute
Former Chairman, 
Nobel Foundation


Dr Amy Butler
Vice President & General Manager of Cell Biology, Thermo Fisher Scientific


Steve Rosenberg
Senior Vice President & General Manager
Oracle Health Sciences

Among his key contributions to the industry are cloud-based solutions including an integrated approach to clinical trial management, new methodologies for patient reported outcomes, and the introduction of advanced analytics for at-risk healthcare payers and providers. As a leader and industry veteran with a range of experiences in life sciences and healthcare technology and services, Rosenberg has the knowledge and experience to address and influence the changing life sciences landscape, utilizing his deep domain understanding, customer relationships, and technology vision. As senior vice president and manager of the Medical Management Division at hPR, Inc. (acquired by McKesson hBOC) and as senior vice president of Development and Client Services at W3health, a healthcare analytic software and services technology startup, Rosenberg gained a unique healthcare perspective to broaden his holistic view of the life sciences industry. These experiences provide him with the payer and provider perspective needed to understand the end-to-end business process and the changing dynamics affecting life sciences R&D. Rosenberg’s experience also includes eight months as chief operating officer for PhT Corporation, a technology and service leader in the electronic patient-reported outcome (ePRO) market space. he was instrumental in developing PhT’s strategy for the patient suite and the patient-centric clinical trial. Most notably, Rosenberg was the visionary and lead evangelist for the integrated clinical technology suite introduced by Phase Forward and used by 9 of the top 10 global biopharmaceutical companies.

As senior vice president of Software and Services at Phase Forward, Rosenberg was an integral member of the senior management team and championed the integrated technology approach. During his tenure, Phase Forward went public in 2005, and with his technology guidance
dominated the clinical R&D solutions market. In 2009, Phase Forward achieved US$213 million in revenue with approximately 1,000 employees and was the #1 clinical R&D solution provider.

PJ Magnus Settergren

Magnus Settergren
Assoc Prof and Interventional Cardiologist
Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden


Eric TopolEric Topol
Executive Vice President and Chair
Innovative Medicine Scripps Research
Director & Founder
Scripps Research Translational Institute
Author, Deep Learning

Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research, As a researcher, he has published over 1200 peer-reviewed articles, with more than 240,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.

In 2016, Topol was awarded a $207M grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program is enrolling 1 million participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. Prior to coming to Scripps in 2007, he led the Cleveland Clinic to become the #1 center for heart care and was the founder of a new medical school there. He has been voted as the #1 most Influential physician leader in the United States in a national poll conducted by Modern Healthcare. Besides editing several textbooks, he has published 2 bestseller books on the future of medicine: The Creative Destruction of Medicine and The Patient Will See You Now. His new book Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again came out in 2019. Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.